Showing Form 4 filings for BMY
Pre-configured institutional-grade criteria for instant high-conviction screening
Multiple insiders buying stock within the last 30 days
Direct open-market purchases by Chief Executive Officers
Financial chiefs and top corporate officers accumulating shares
Institutional-scale insider purchases of $1,000,000 or greater
Insiders increasing their overall equity ownership by over 20%
High-value executive divestments by CEOs and CFOs over $1M
BMY
Price
$64.57
Shares
6,249
Ownership
18,748
Value/Share
Massacesi Cristian
EVP,Chief Med Offr,Head of Dev
Unknown
Industry
$67.50
500
16,862
Holzer Phil M
SVP, Controller
$61.67
30,000
159,542
Elkins David V
EVP, CFO
$47.33
56,000
167,662
$38.01
97
8,789
$38.16
Hickey Benjamin
Pres, RayzeBio Org.
$47.58
4,250
83,513
Hirawat Samit
EVP,Chief Med.Offr.,Drug Dev.
$55.05
2,000
104,626
Boerner Christopher S.
CEO
$54.84
1,823
63,932
$54.85